WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TLSI

Based on 1 analyst offering 12 month price targets for Trisalus Life Sciences Inc

Min Forecast
$7.00+54.53%
Avg Forecast
$7.00+54.53%
Max Forecast
$7.00+54.53%

Should I buy or sell TLSI stock?

Based on 1 analyst offering ratings for Trisalus Life Sciences Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TLSI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TLSI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TLSI stock forecasts and price targets.

TLSI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-09

1 of 1

Forecast return on equity

Is TLSI forecast to generate an efficient return?

Company
N/A
Industry
29.09%
Market
156.87%

Forecast return on assets

Is TLSI forecast to generate an efficient return on assets?

Company
N/A
Industry
14.95%

TLSI earnings per share forecast

What is TLSI's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.38
Avg 2 year Forecast
-$0.07
Avg 3 year Forecast
$0.27

TLSI revenue forecast

What is TLSI's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$61.2M+35.45%
Avg 2 year Forecast
$84.1M+86.35%
Avg 3 year Forecast
$114.2M+152.95%
TLSI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TLSI revenue growth forecast

How is TLSI forecast to perform vs Medical Devices companies and vs the US market?

Company
35.58%
Industry
9.14%
Market
14.33%
TLSI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TLSI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TLSI vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TLSI$4.53$7.00+54.53%Strong Buy
MASS$7.26N/AN/A
SI$13.88$21.67+56.10%Strong Buy
SENS$6.87$16.75+143.81%Strong Buy
RXST$7.09$10.00+41.04%Hold
View Top Medical Device Stocks

Trisalus Life Sciences Stock Forecast FAQ

Is Trisalus Life Sciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TLSI) stock is to Strong Buy TLSI stock.

Out of 1 analyst, 1 (100%) are recommending TLSI as a Strong Buy, 0 (0%) are recommending TLSI as a Buy, 0 (0%) are recommending TLSI as a Hold, 0 (0%) are recommending TLSI as a Sell, and 0 (0%) are recommending TLSI as a Strong Sell.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.

What is TLSI's earnings growth forecast for 2026-2028?

(NASDAQ: TLSI) Trisalus Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.85%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.65%.

Trisalus Life Sciences's earnings in 2026 is -$69,690,000.On average, 7 Wall Street analysts forecast TLSI's earnings for 2026 to be -$23,511,019, with the lowest TLSI earnings forecast at -$27,636,942, and the highest TLSI earnings forecast at -$17,380,375. On average, 8 Wall Street analysts forecast TLSI's earnings for 2027 to be -$4,273,059, with the lowest TLSI earnings forecast at -$15,620,880, and the highest TLSI earnings forecast at $13,518,069.

In 2028, TLSI is forecast to generate $16,675,351 in earnings, with the lowest earnings forecast at -$1,201,606 and the highest earnings forecast at $38,623,055.

What is TLSI's revenue growth forecast for 2026-2028?

(NASDAQ: TLSI) Trisalus Life Sciences's forecast annual revenue growth rate of 35.58% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.14%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.33%.

Trisalus Life Sciences's revenue in 2026 is $45,151,000.On average, 7 Wall Street analysts forecast TLSI's revenue for 2026 to be $3,749,440,380, with the lowest TLSI revenue forecast at $3,529,718,110, and the highest TLSI revenue forecast at $3,919,259,211. On average, 8 Wall Street analysts forecast TLSI's revenue for 2027 to be $5,158,323,609, with the lowest TLSI revenue forecast at $4,506,023,120, and the highest TLSI revenue forecast at $5,877,448,115.

In 2028, TLSI is forecast to generate $7,001,808,170 in revenue, with the lowest revenue forecast at $6,374,643,319 and the highest revenue forecast at $7,583,606,257.

What is TLSI's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TLSI) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 14.95%.

What is TLSI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TLSI price target, the average TLSI price target is $7.00, with the highest TLSI stock price forecast at $7.00 and the lowest TLSI stock price forecast at $7.00.

The Wall Street analyst predicted that Trisalus Life Sciences's share price could reach $7.00 by Mar 9, 2027. The average Trisalus Life Sciences stock price prediction forecasts a potential upside of 54.53% from the current TLSI share price of $4.53.

What is TLSI's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TLSI) Trisalus Life Sciences's current Earnings Per Share (EPS) is -$1.84. On average, analysts forecast that TLSI's EPS will be -$0.38 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.28. On average, analysts forecast that TLSI's EPS will be -$0.07 for 2027, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at $0.22. In 2028, TLSI's EPS is forecast to hit $0.27 (min: -$0.02, max: $0.63).

What is TLSI's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TLSI) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.